Context This overview presents the updated European Association of Urology (EAU)
guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective To …

CONTEXT: New guidelines of the International Consultation on Urological Diseases for the
treatment of muscle-invasive bladder cancer (MIBC) have recently been published …

Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

Abstract Context The European Association of Urology (EAU) guidelines panel on Muscle-
invasive and Metastatic bladder cancer (BCa) updates its guidelines yearly. This updated …

Background Although guidelines exist for advanced and variant bladder cancer
management, evidence is limited/conflicting in some areas and the optimal approach …

Background Concerns remain whether robot-assisted radical cystectomy (RARC)
compromises survival because of inadequate oncologic resection or alteration of recurrence …

CONTEXT: Follow-up of patients treated for bladder cancer (BCa) is of great importance for
both non–muscle-invasive BCa (NMIBC) and muscle-invasive BCa (MIBC) because of the …

CONTEXT: The role of lymph node dissection (LND) in patients treated with radical
nephroureterectomy (RNU) for upper tract urothelial cancer (UTUC) is still controversial …

Background Although guidelines exist for advanced and variant bladder cancer
management, evidence is limited/conflicting in some areas and the optimal approach …

Context Urothelial carcinoma is considered a pan-urothelial disease. As such, the remnant
urothelium in the upper urinary tract and urethra following radical cystectomy (RC) remains …